Integrated Core Strategies (US) LLC 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 4:36 pm Sale | 2023-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | Integrated Core Strategies (US) LLC | 132,674 4.900% | -1,029 (-0.77%) | Filing |
| 2023-01-17 4:38 pm Purchase | 2023-01-04 | 13G | Kala Pharmaceuticals, Inc. KALA | Integrated Core Strategies (US) LLC | 133,703 8.400% | 133,703 (New Position) | Filing |